Generation Bio Co. (GBIO) Comparison with companies in other sectors?

Generation Bio Co. has a share price of 67.04M. You can analyze Generation Bio Co. (GBIO) competitors across different market sectors through stock heatmaps.

What are GBIO's NET and operating margins?

Generation Bio Co. (GBIO) operating margin is around -3.31, and net profit margin is approximately -2.93 as of the latest reports.

In what way does GBIO's earnings per share (EPS) trend reflect its financial momentum?

Generation Bio Co. (GBIO) EPS is -1.08 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Generation Bio Co. is -3.95, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Generation Bio Co.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Generation Bio Co. like P/E which is -3.84, P/B which is 3.77, and PEG which is -0.08. Compare them with sector averages to evaluate if the stock is priced fairly.

Generation Bio Co.

GBIO•NASDAQ

Healthcare

Biotechnology

$4.27

$0.06(1.43%)

Fundamental Analysis of Generation Bio Co. (GBIO)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-1.08

P/E Ratio

-3.95

ROE

-0.76%

Net Margin

-2.93%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$286.24M

Shares OutstandingTotal number of shares issued

$67.04M

Book Value/ShareNet worth per share

$1.09

Revenue/ShareAnnual revenue per share

$0.37

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-1.08

Net MarginNet income as percentage of revenue

-292.92%

Operating MarginOperating income as percentage of revenue

-331.33%

ROEReturn on shareholders' equity

-75.84%

ROAReturn on total assets

-35.72%

ROCEReturn on capital employed

-44.77%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-1.28

Cash/ShareCash and equivalents per share

$2.35

FCF YieldFree cash flow as percentage of market cap

-29.96%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for GBIOFinancial Ratios Analysis details for GBIO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for GBIOSector Benchmarking details for GBIO are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Generation Bio Co. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Generation Bio Co.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Generation Bio Co.'s unique business strengths and challenges.

Key Financial Metrics for Generation Bio Co.

For Generation Bio Co., essential financial indicators include EPS -1.08, PE -3.95, and ROE -0.76. These key ratios reveal insights into Generation Bio Co.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Generation Bio Co. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Generation Bio Co.

Metrics like Net Margin -292.92% and ROA -35.72% shed light on how well Generation Bio Co. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Generation Bio Co. can sustain its operations and continue growing in the future.

Valuation and Market Position of Generation Bio Co.

Using ratios such as P/B Ratio 3.77 and PEG Ratio -0.08, investors can assess whether Generation Bio Co. is appropriately valued based on its financials and growth potential. These figures, combined with Generation Bio Co.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Generation Bio Co.

Financial health indicators, such as Debt/Equity Ratio 1.19 and Cash Flow $-1.28, provide a snapshot of Generation Bio Co.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Generation Bio Co., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Generation Bio Co.

Investing in Generation Bio Co. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Generation Bio Co. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;